Factors Associated With Physicians’ Reliance on Pharmaceutical Sales Representatives
- 1 August 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Academic Medicine
- Vol. 84 (8), 994-1002
- https://doi.org/10.1097/acm.0b013e3181ace53a
Abstract
Purpose To examine relationships between pharmaceutical representatives and obstetrician-gynecologists and identify factors associated with self-reported reliance on representatives when making prescribing decisions. Method In 2006-2007, questionnaires were mailed to 515 randomly selected physicians in the American College of Obstetricians and Gynecologists’ Collaborative Ambulatory Research Network. Participants were asked about the information sources used when deciding to prescribe a new drug, interactions with sales representatives, views of representatives’ value, and guidelines they had read on appropriate industry interactions. Results Two hundred fifty-one completed questionnaires (49%) were returned. Seventy-six percent of participants see sales representatives’ information as at least somewhat valuable. Twenty-nine percent use representatives often or almost always when deciding whether to prescribe a new drug; 44% use them sometimes. Physicians in private practice are more likely than those in university hospitals to interact with, value, and rely on representatives; community hospital physicians tend to fall in the middle. Gender and age are not associated with industry interaction. Dispensing samples is associated with increased reliance on representatives when making prescribing decisions, beyond what is predicted by a physician’s own beliefs about the value of representatives’ information. Reading guidelines on physician-industry interaction is not associated with less reliance on representatives after controlling for practice setting. Conclusions Physicians’ interactions with industry and their familiarity with guidelines vary by practice setting, perhaps because of more restrictive policies in university settings, professional isolation of private practice, or differences in social norms. Prescribing samples may be associated with physicians’ use of information from sales representatives more than is merited by the physicians’ own beliefs about the value of pharmaceutical representatives.Keywords
This publication has 15 references indexed in Scilit:
- Characteristics of Patients Receiving Pharmaceutical Samples and Association Between Sample Receipt and Out-of-Pocket Prescription CostsMedical Care, 2008
- ACOG Committee Opinion No. 401: Relationships With IndustryObstetrics & Gynecology, 2008
- Following the Script: How Drug Reps Make Friends and Influence DoctorsPLoS Medicine, 2007
- Interactions of doctors with the pharmaceutical industryJournal of Medical Ethics, 2006
- Do drug samples influence resident prescribing behavior? A randomized trialAmerican Journal Of Medicine, 2005
- Interactions between pharmaceutical representatives and doctors in trainingJournal of General Internal Medicine, 2005
- The quantity and quality of scientific graphs in pharmaceutical advertisementsJournal of General Internal Medicine, 2003
- Effect of Restricting Contact Between Pharmaceutical Company Representatives and Internal Medicine Residents on Posttraining Attitudes and BehaviorJAMA, 2001
- Physicians, pharmaceutical sales representatives, and the cost of prescribingArchives of Family Medicine, 1996
- Rational prescribing and sources of informationSocial Science & Medicine (1982), 1982